eGain (EGAN) Tops Q3 EPS by 7c

eGain (NASDAQ: EGAN) reported Q3 EPS of $0.11, $0.07 better than the analyst estimate of $0.04. Revenue for the quarter came in at $22.5 million versus the consensus estimate of $22.25 million.

GUIDANCE:

eGain sees Q4 2026 EPS of $0.02-$0.05, versus the consensus of $0.03. eGain sees Q4 2026 revenue of $21.5-22 million, versus the consensus of $22.7 million.

eGain sees FY2026 EPS of $0.39-$0.42, versus the consensus of $0.36. eGain sees FY2026 revenue of $90.5-91 million, versus the consensus of $91.64 million.

For earnings history and earnings-related data on eGain (EGAN) click here.

You May Also Be Interested In

• Ardent Health Partners, Inc. (ARDT) Tops Q3 EPS by 8c; offers guidance
• FatPipe, Inc. (FATN) Reports Q3 EPS of $0.09
• Myriad Genetics (MYGN) Tops Q3 EPS by 9c ; Offers Guidance